Organovo Holdings, Inc. (ONVO) is an interesting player in the Healthcare space, with a focus on Medical Laboratories & Research. The stock has been active on the tape, currently trading at $1.70, down from yesterday’s close by -2.30%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Organovo Holdings, Inc. (ONVO) currently trades with a market capitalization of $182.49 Million. That value represents a market adjusting for revenues that have been growing by 0.17 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$30.85 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of -$0.07 on a per share basis this quarter. Perhaps, that suggests something about why 14.50% of the outstanding share supply is held by institutional investors.
As most professionals know, technical analysis can offer critical insights into what smart money and insiders think about a stock’s prospects going forward. Looking at the stock’s movement on the chart, Organovo Holdings, Inc. recorded a 52-week high of $3.19. It is now trading 1.49% off that level. The stock is trading $1.14 its 50-day moving average by -0.56%. The stock carved out a 52-week low down at $0.91.
In recent action, Organovo Holdings, Inc. (ONVO) has made a move of +42.86% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.61, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 14.04% with $103.64 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of ONVO.